M. Cebi Et Al. , "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS," Frontiers in Immunology , vol.11, 2020
Cebi, M. Et Al. 2020. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology , vol.11 .
Cebi, M., DURMUŞ TEKÇE, H., Aysal, F., ÖZKAN, B., Gul, G. E., ÇAKAR, A., ... Hocaoglu, M.(2020). CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology , vol.11.
Cebi, Merve Et Al. "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS," Frontiers in Immunology , vol.11, 2020
Cebi, Merve Et Al. "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS." Frontiers in Immunology , vol.11, 2020
Cebi, M. Et Al. (2020) . "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS." Frontiers in Immunology , vol.11.
@article{article, author={Merve Cebi Et Al. }, title={CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS}, journal={Frontiers in Immunology}, year=2020}